Evidence map›Paper›PMID 25962936›Full record

ArticleGastroenterology2015

Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.

Szabolcs Fatrai, Susanne J van Schelven, Inge Ubink, Klaas M Govaert, Danielle Raats, Jan Koster, Andre Verheem, Inne H M Borel Rinkes, Onno Kranenburg

Abstract read
PubMed Publisher
In one paragraph

Article in Gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. [PreS1 Antigen of HBV Down-Regulates MHC-Ⅰ on the Surface of Hepatocytes and Promotes Hepatocarcinogenesis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Research advances of secretory proteins in malignant tumors.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Szabolcs FatraiDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Susanne J van SchelvenDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Inge UbinkDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Klaas M GovaertDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Danielle RaatsDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Jan KosterDepartment of Oncogenomics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Andre VerheemDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Inne H M Borel RinkesDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Onno KranenburgDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: o.kranenburg@umcutrecht.nl.
University Medical Center Utrecht · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsColon tumors contain a fraction of undifferentiated stem cell-like cancer cells with high tumorigenic potential. Little is known about the signals that maintain these stem-like cells. We investigated whether differentiated tumor cells provide support.

methodsWe established undifferentiated colonosphere cultures from human colon tumors and used them to generate stably differentiated cell lines. Antibody arrays were used to identify secreted factors. Expression of genes involved in stemness, differentiation, and the epithelial to mesenchymal transition was measured using reverse transcription quantitative polymerase chain reaction. Expression of KIT in human tumors was analyzed with gene expression arrays and by immunohistochemistry. Colonospheres were injected into the livers of CBy.Cg-Foxn1nu/J mice. After liver tumors had formed, hypoxia was induced by vascular clamping.

resultsDifferentiated cells from various tumors, or medium conditioned by them, increased the clonogenic capacity of colonospheres. Stem cell factor (SCF) was secreted by differentiated tumor cells and supported the clonogenic capacity of KIT(+) colonosphere cells. Differentiated tumor cells induced the epithelial to mesenchymal transition in colonosperes; this was prevented by inhibition of KIT or SCF. SCF prevented loss of clonogenic potential under differentiation-inducing conditions. Suppression of SCF or KIT signaling greatly reduced the expression of genes that regulate stemness and the epithelial to mesenchymal transition and inhibited clonogenicity and tumor initiation. Bioinformatic and immunohistochemical analyses revealed a correlation between expression of KIT- and hypoxia-related genes in colon tumors, which was highest in relapse-prone mesenchymal-type tumors. Hypoxia induced expression of KIT in cultured cells and in human colon tumor xenografts and this contributed to the clonogenic capacity of the tumor cells.

conclusionsParacrine signaling from SCF to KIT, between differentiated tumor cells and undifferentiated stem-like tumor cells, helps maintain the stem-like features of tumor cells, predominantly under conditions of hypoxia.

Indexed as

Cell DifferentiationParacrine CommunicationAnimalsBiomarkers, TumorCell HypoxiaCell ProliferationCoculture TechniquesColonic NeoplasmsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansMice, NudeNeoplastic Stem CellsProtein Kinase InhibitorsProto-Oncogene Proteins c-kitSignal TransductionBiomarkers, TumorProtein Kinase InhibitorsProto-Oncogene Proteins c-kitStem Cell FactorColon Cancer ModelColorectalNicheTumor Progression

Identifiers

PMID25962936
OpenAlexW1787256923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.